Africa: Vaccines Deliver Over U.S.$30 Billion in Economic Benefits for Lower-Income Countries in 2025

[GAVI] Gavi-supported immunisation generated more than US$ 30 billion in economic benefits in 2025, through lower healthcare costs and healthier, more productive populations Recognising the value of immunisation, countries invested a record US$ 301 million in co-financing of Gavi-supported vaccines in 2025 Dr Sania Nishtar, Gavi CEO: "When it comes to immunisation we know that the return on investment extends far beyond health to supporting sustainable, inclusive economic growth."